NASDAQ:NBP | Free Cash Flow | NovaBridge Biosciences

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$14.6M$0.00-$14.6M
2024-12-31-$10.95M$38,000.00-$10.99M
2020-12-31$152.26M$526,000.00$151.73M97.13%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$20.6M$7,000.00-$20.6M
2024-12-31-$52.67M$48,000.00-$52.72M
2023-12-31-$183.8M$164,000.00-$183.96M
2022-12-31-$159.89M$2.09M-$161.98M
2021-12-31-$152.7M$4.7M-$157.4M
2020-12-31$66.45M$1.23M$65.22M90.37%
2019-12-31-$124.68M$1.76M-$126.44M